← Oncology Approval Tracker

FDA DECISION ·

Ziihera

zanidatamab-hrii · Jazz Pharmaceuticals

Accelerated approvalNew therapyBiliary tract cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with previously treated, unresectable or metastatic biliary tract cancer that is HER2 IHC 3+ on an FDA-approved test.

LAMPGEN ANALYSIS

Why it matters

The first 2024 Ziihera indication provided HER2-directed treatment for a narrowly defined biliary population.

What research teams should watch

Capture the exact HER2 IHC score and prior treatment; set up cardiac assessment and infusion reaction response.

PRIMARY RECORDS

Sources